AMI Investment Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.58M Sell
6,671
-639
-9% -$237K 0.55% 41
2026
Q1
$2.14M Buy
7,310
+454
+7% +$149K 0.48% 43
2025
Q4
$2.4M Buy
6,856
+283
+4% +$95.6K 0.54% 41
2025
Q3
$2.12M Buy
6,573
+1,015
+18% +$316K 0.49% 44
2025
Q2
$2.16M Buy
5,558
+272
+5% +$109K 0.56% 40
2025
Q1
$2.3M Buy
5,286
+851
+19% +$342K 0.74% 37
2024
Q4
$1.64M Buy
4,435
+1,947
+78% +$815K 0.53% 41
2024
Q3
$1.29M Buy
+2,488
New +$1.33M 0.44% 45

Other funds holding ELV

AMI Investment Management's ELV Position: Q2 2026 in Review

AMI Investment Management reduced its Elevance Health (ELV) stake by 8.7% in Q2 2026, selling an estimated $237K and leaving 6,671 shares worth $2.58M. The position accounts for 0.55% of the portfolio, ranked #41.

AMI Investment Management first reported a position in ELV in Q3 2024 and has held it in 8 quarters since. 637 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • AMI Investment Management held 6,671 shares of Elevance Health worth $2.58M as of Q2 2026.
  • AMI Investment Management sold 639 Elevance Health shares in Q2 2026, an estimated $237K.
  • Elevance Health made up 0.55% of AMI Investment Management's portfolio in Q2 2026, its #41 holding.
  • AMI Investment Management first reported a position in Elevance Health in Q3 2024 and has held it in 8 quarters since.
  • 637 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on AMI Investment Management's 13F filing for Q2 2026, filed 15 Jul 2026.